Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.
about
Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up StudiesTranslational challenges of animal models in Chagas disease drug development: a reviewRevisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?Ten years of Chagas disease research: Looking back to achievements, looking ahead to challengesInterferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients.Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping reviewTarget Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participationAnalytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease PatientsSerological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaChagas disease research and development: Is there light at the end of the tunnel?Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Chagas disease drug discovery: toward a new era.Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform.Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell ResponsesA 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease.Analytical sensitivity and specificity of a loop-mediated isothermal amplification (LAMP) kit prototype for detection of Trypanosoma cruzi DNA in human blood samples.Molecular diagnostics for Chagas disease: up to date and novel methodologies.Antiparasitic Treatment Induces an Improved CD8+ T Cell Response in Chronic Chagasic Patients.Biosensors to Diagnose Chagas Disease: A Brief Review.First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease.The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
P2860
Q26738824-085500FB-816B-4403-9DE2-52F7A3B6FAD9Q26782118-E19F7AA5-4177-477D-A691-0FF15695B9B7Q26796451-A46298D4-2D03-4283-8E70-4669EFDF9ECCQ26859040-002F367F-C2E3-4B01-A578-0BEBCFE46B06Q28555229-2C2807CE-3A89-418B-BB2C-EB792E7D321BQ33584473-9F067BE1-3954-4234-8328-15BF4CAD255DQ34179046-14342C17-AF55-4797-8A93-6C672E028B3CQ35122764-AA2ACD5E-38F6-4DE9-9C8F-5F3F00E1EF9CQ35204314-E96111BD-86AF-4BD5-9A2F-02D8B9CFD574Q35601427-5FE17B47-0D94-46CA-A16E-5B3BDBFE9DB4Q35652603-FA324DD1-813D-4811-B7F9-1D3A30ECD03CQ35810790-04E0D013-E6C7-4FBD-811D-3108B1071536Q36278397-8F037C43-916C-414A-98CB-D58BF93D0E0BQ36423574-3EC53F6C-3EF4-4FB9-ABCC-77FD97BEB95BQ37007518-47D77263-ED57-402A-B465-C6E0D998DE24Q37541623-8D787334-BB9D-4FAE-AC41-2D42F2A2CFA1Q37717875-D0C9AB48-3057-4E72-A696-5D58C301F3B4Q38253281-6748D636-8CB9-4400-876A-9D31D2605019Q38256874-C3189955-B6FE-4387-91B1-018CA33205DBQ38640312-8CFC6664-0E23-4C2E-8CEF-27F1D8FF9441Q38845466-D1FA0FFE-D773-4952-A7FA-63BAB1F53444Q38871286-3F34A0E9-D163-42DE-9FDB-225029A37C3BQ39002789-ED67F03C-246C-41AE-A110-FEFA1B68F2F6Q40126468-2AF96C0D-B92A-4D17-82BB-FEBA3B67D4EFQ40184873-B931967C-4AB9-419B-B7C0-E5412856B78DQ40309242-91EC1F57-5C01-4F27-9132-AE61B6B7680DQ46035700-EB23E40F-48FB-4784-8AB8-D95CB98DA489Q47109604-F0BB55D0-9E3F-49E9-90F9-248ACDE28E0EQ48243287-E61CF8DD-CA3B-4D4C-A1EF-A3C7DC80B9CBQ50099507-236673C4-A856-4829-BED8-4F3ABE236135Q55082571-4A8BA9E9-882F-4B67-A854-D1E09B199A18Q58573679-BAB00092-E146-47DB-B918-CABB72E1C10D
P2860
Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biological markers for evaluat ...... disease, a systematic review.
@en
type
label
Biological markers for evaluat ...... disease, a systematic review.
@en
prefLabel
Biological markers for evaluat ...... disease, a systematic review.
@en
P2093
P2860
P50
P1476
Biological markers for evaluat ...... s disease, a systematic review
@en
P2093
Alejandro-Gabriel Schijman
Alina Perrone
Isabela Ribeiro
Jacqueline Bua
Janine-M Ramsey
Rodolfo-Jorge Viotti
Sergio Sosa-Estani
P2860
P304
P356
10.1586/14787210.2014.899150
P577
2014-04-01T00:00:00Z